Collaboration agreements - Janssen Biotech (Details) $ in Thousands |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|---|
Feb. 28, 2022
USD ($)
target
performanceObligation
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
|
Collaboration agreements | |||||||
Collaboration revenue | $ 7,698 | $ 5,573 | $ 26,154 | $ 11,893 | |||
Deferred revenue | 133,096 | 132,341 | 133,096 | 132,341 | $ 147,653 | $ 3,944 | |
Janssen Agreement | |||||||
Collaboration agreements | |||||||
Number of targets designated | target | 3 | ||||||
Upfront payment received | $ 40,000 | ||||||
Performance obligations identified | performanceObligation | 7 | ||||||
Revised transaction price | 48,000 | 48,000 | |||||
Transaction price adjustment | 6,000 | ||||||
Collaboration revenue | 4,900 | $ 4,900 | 14,000 | $ 10,900 | |||
Deferred revenue | $ 9,900 | $ 9,900 | $ 15,800 |
X | ||||||||||
- Definition Number of targets designated as of balance sheet date. No definition available.
|
X | ||||||||||
- Definition The number of material performance obligations identified under a collaboration arrangements related to designated targets No definition available.
|
X | ||||||||||
- Definition The aggregate transaction price of a collaboration agreement as of the balance sheet date. No definition available.
|
X | ||||||||||
- Definition The increase (decrease) in the estimated transaction price of a collaborative agreement during the period, No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Cash received from collaborators during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|